Skip to content
Delayed ~15 min

LUCD LUCID DIAGNOSTICS INC

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Wed 11 Nov 2026 · estimated

What 7 analyst firms say about LUCID DIAGNOSTICS INC: their latest ratings, price targets and how far the stock is from them. How it works

0.40 USD+0.01 (+2.03%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+905.0%to the avg target 4.00 USD+3.60 USD
Buy 5 · Hold 1 · Sell 0

6 rated views · 7 analyst/firm records · 7 firms

Latest report23 Oct 2026avg report date 22 Aug
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
  • Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD

Recent analyst activity · last 90 days

Our tracked history has 6 reports on LUCD from 5 analyst firms in the last 90 days (7 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target and 3 left it unchanged.

No firm's latest available rating differs from its previous one.

Latest observed target change: Ascendiant Capital raised its target from $9.25 (set 8 Jun 2026) to $9.50 on 27 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Ascendiant Capital MarketsEdward M WooBuy27 Aug 20269.50 USD
BTIGMark MassaroBuy23 Oct 20262.50 USD
Canaccord GenuityKyle MiksonBuy14 May 20263.00 USD
Maxim GroupAnthony V VendettiBuy14 Aug 20262.00 USD
NeedhamMichael MatsonBuy1 Oct 20263.00 USD
Weiss RatingsUnnamed analyst—18 Aug 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 03:40 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.